Special Issue "Nutraceuticals and Their Medicinal Importance"
Deadline for manuscript submissions: 30 August 2018
Dr. Francesca Giampieri
Department of Odontostomatologic and Specialized Clinical Sciences, Sez-Biochimica, Faculty of Medicine, Università Politecnica delle Marche, Via Ranieri 65, 60100 Ancona, Italy
Interests: nutrition; health; bioactive compounds; polyphenols; antioxidants; free radicals; oxidative stress; aging; mitochodrial functionality; apoptosis; strawberry, honey
The term “nutraceuticals” was introduced by Stephen DeFelice, founder and chairman of the Foundation for Innovation in Medicine, in 1989. A nutraceutical is defined as a “food, or parts of a food, that provide medical or health benefits, including the prevention and treatment of disease”. This definition includes medicinal products made from natural ingredients. Several classes of nutraceuticals have been proposed to have potential benefits in the treatment of many human pathologies, such as cardiovascular diseases, cancer, diabetes and metabolic syndrome, osteoporosis and arthritis, with consequences on quality of life and longevity. Recently, nutraceuticals have been included in conventional therapies, allowing to reduce their dosages and adverse effects. At the same time, consumers have become aware all around the world that nutraceuticals may exert specific roles at different times throughout life and may help to maintain a good health and prevent diseases. In fact, the global annual increase of nutraceutical market is of about 15%.The main aims of the Special Issue on "Nutraceuticals and Their Medicinal Importance" is to be an open forum where researchers may share their investigations and findings in this promising field and, thanks to the open access platform, increase their visibility and the chances to interact with industries and the production systems. Contributions to this issue, both in the form of original research or review articles, may cover all aspects of nutraceuticals; studies with multidisciplinary input, offering new methodologies or insights, are particularly welcome.
Dr. Francesca Giampieri
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- bioactive compounds
- functional foods
- medicinal products
- disease prevention
- quality control
- food processing techniques
- safety and efficacy
- dietary supplements
- commercialization of nutraceuticals and functional foods
- economic and industry opportunities
- labelling and health claims
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Use of nutraceuticals in angiogenesis dependent disorders
Lucia Morbidelli, Erika Terzuoli, Sandra Donnini
Dept. Life Sciences, University of Siena
Abstract: Angiogenesis, the development of new vessels form pre-existing ones, is a prerequisite for both physiological growth, repair and functioning of our organs, but also concurs to pathological conditions, as cancer, eye diseases, chronic degenerative disorders as examples. In most of the cases an inflammatory and oxidative condition exists, supporting angiogenesis deregulation.
The use of nutraceuticals with antioxidant and anti-inflammatory activities can be a therapeutic option to maintain an adequate vascularization and endothelial cell proper functioning. The state of the art and mechanisms reported for nutraceutical to guide endothelial cell wellness and to restore physiological tissue vascularization will be the topic of the chapter. The critical issues as well as lacking information for human use will be explored under a pharmacological point of view.